German Chemicals lobby warns that growth in Asia is hurting the recovery
VCI, the main lobby group for Germany's chemical industry, warned on Thursday that it expects its production, which includes pharmaceuticals, will fall by 1.5% in 2026. It also said that a weak European market and a shift in investment to Asia have undermined hopes of a sustainable recovery.
The association predicted that the manufacturing sector would continue to experience a decline in output due to weak sales, rising costs, and low investment. This is a major pillar for Germany's manufacturing industry.
VCI reported that production in Germany's chemical industry and pharmaceutical industry declined by 3% during the first half 2026. Sales, however, fell by 1% to 123.4 billion euros. Producer prices increased 2%.
Markus Steilemann, VCI's President, said that the half-year results were "disappointing".
Steilemann, in a recent press conference, said that the European demand for chemicals is at best stagnant, and in some cases even declining.
Years ago, European chemical producers benefited from exports into fast-growing Asian markets. As customers in China and other parts of Asia expanded, companies began to shift production closer to these markets, which reduced exports. Steilemann stated that the rise in local production in Asia is displacing imports from German and European producers.
The group had declined to publish industry predictions in March and may due to the uncertainty surrounding the conflict. However, any recent improvement in conditions is unlikely to be the beginning of a larger?turnaround.
VCI stated that disruptions linked to the conflict temporarily benefited European chemical producers while hurting Asian competitors who depended more on feedstock. VCI said the disruptions?linked to the conflict had temporarily benefited some European chemical producers by hurting more feedstock-dependent Asian competitors.
The outlook is a contrast to the growing optimism of some companies. Evonik Industries, Brenntag and both have recently increased their "full-year profits forecasts".
The chemical and pharmaceutical industry in Germany is the third largest industrial sector and is widely regarded as a bellwether of manufacturing demand. It supplies materials to industries such as autos, construction, agriculture and textiles.
(source: Reuters)